Fig. 1 (IMAGE)

The University of Osaka

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

NUTM1 rearrangements cause a highly treatable form of infant leukemia

The University of Osaka

Journal: Blood
Funder: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, Japan Science and Technology Agency, American Society of Hematology, Japanese Society of Hematology, Leukemia and Lymphoma Society, National Cancer Institute, NIH/National Institutes of Health, National Heart, Lung, and Blood Institute, the Edward P. Evans MDS Foundation, Senri Life Science Foundation, Sumitomo Foundation, Mitsubishi Foundation, KAKETSUKEN, Bristol-Myers Squibb Foundation, Astellas Foundation for Research on Metabolic Disorders, Mochida Memorial Foundation for Medical and Pharmaceutical Research, Japan Leukemia Research Fund, Princess Takamatsu Cancer Research Fund, Morgan Adams Foundation, Naito Foundation, Takeda Science Foundation, Friends of Leukemia Research Fund, MSD Life Science Foundation, Japan Foundation for Pediatric Research, the Funai Foundation for Information Technology, Honjo International Scholarship Foundation
DOI: 10.1182/blood.2024026928

Fig. 2

Fig. 3

https://resou.osaka-u.ac.jp/en

Fig. 1 (IMAGE)

Caption

Credit

Usage Restrictions

License